Inflammatory bowel disease (IBD)
- Distinguish Crohn disease from ulcerative colitis
- Mild UC often starts with mesalamine
- Moderate–severe disease increasingly uses early advanced therapy
- Steroids induce remission but should not maintain it
- Biologics/small molecules are chosen by phenotype + prior exposure
- Monitor objective inflammation, not symptoms alone
Use at a glance
- Distinguish Crohn disease from ulcerative colitis
Choosing treatment
- Steroids induce remission but should not maintain it
- Biologics/small molecules are chosen by phenotype + prior exposure
Treatment options
- Mild UC often starts with mesalamine
- Moderate–severe disease increasingly uses early advanced therapy
Monitoring / follow-up
- Monitor objective inflammation, not symptoms alone
Self-check
- What is monitored in IBD beyond symptoms?
Objective inflammation, not symptoms alone. - Should steroids maintain IBD remission?
No—induction only.
Drugs used for this (11)
All clinical uses · Open Inflammatory bowel disease (IBD) in the interactive console ↗